Kueh, C. J.L., Connelly, P. , Harte, R., Smith, C. and Boyle, J. G. (2017) The impact of dapagliflozin on HbA1c, systolic blood pressure and weight: a review of dapagliflozin use in a Scottish city. Practical Diabetes, 34(4), pp. 129-130. (doi: 10.1002/pdi.2100)
Full text not currently available from Enlighten.
Abstract
We aimed to determine the efficacy of dapagliflozin in the management of type 2 diabetes in a Scottish population through measurements of glycaemic control, blood pressure and weight. Dapagliflozin was effective in improving HbA1c by 10 mmol/mol (SE 1.8, p < 0.001), systolic blood pressure by 9.8mmHg (SE 2.2, p < 0.001) and weight by 3.2 kg (SE 0.6, p < 0.001). There was a significant proportion of people with diabetes who reported side effects with dapagliflozin relating to genital and urinary tract infections. Dapagliflozin appears to be an effective drug in improving HbA1c, systolic blood pressure and weight in people with type 2 diabetes. However, in this cohort a substantial proportion of people with diabetes did not tolerate this drug due to side effects.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Boyle, Dr James and Connelly, Dr Paul and Smith, Dr Christopher and Kueh, Mr Christopher |
| Authors: | Kueh, C. J.L., Connelly, P., Harte, R., Smith, C., and Boyle, J. G. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing |
| Journal Name: | Practical Diabetes |
| Publisher: | Wiley |
| ISSN: | 2047-2897 |
| ISSN (Online): | 2047-2900 |
| Published Online: | 19 May 2017 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details